The peptide referred to as SLU-PP-332 (or sometimes simply SLU-PP) is a synthetic research compound known as an exercise mimetic. It acts as a pan-agonist for the estrogen-related receptors (ERRα, ERRβ, and ERRγ) and is being researched for its potential to improve metabolic health and enhance physical endurance at a cellular level.

• Increased Fat Metabolism: It promotes the body to burn fatty acids for energy rather than storing them, leading to decreased fat mass and potential weight loss.
• Enhanced Endurance: Mice treated with SLU-PP-332 showed significant improvements in running endurance and stamina.
• Improved Mitochondrial Function: It boosts mitochondrial biogenesis (creation of new mitochondria) and efficiency, which increases cellular energy production.
• Better Insulin Sensitivity: The compound has been shown to improve glucose metabolism and insulin sensitivity, suggesting potential for treating conditions like type 2 diabetes and metabolic syndrome.
• Organ Protection: Research indicates potential benefits for the heart and kidneys by improving metabolism and reducing inflammation in these tissues.